Experimental colitis induced by trinitrobenzenesulfonic acid: An ultrastructural and histochemical study

Digestive Diseases and Sciences

Volumn 44, Issue 12, 1999, Pages 2523-2529

  Torrres, M I ^a,b   Garcia Martin M ^a   Fernandez M I ^a   Nieto, N ^a   Gil, A ^a   Rios A ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Histology; Inflammatory bowel disease; Trinitrobenzenesulfonic acid; Ultrastructure

Indexed keywords

MUCIN; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; GOBLET CELL; HISTOCHEMISTRY; INTESTINE CRYPT; INTESTINE WALL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ULTRASTRUCTURE;

EID: 0033376459     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026651408998     Document Type: Article

References (38)

1. 1. De Dombal FT: The epidemiology of inflammatory bowel disease. In Inflammatory Bowel Disease. Some International Data and Reflexions. FT De Dombal, J Myren, IAD Bouchier, G Watkinson (eds). Oxford University Press, 1986. pp 66-93
2. 2. Isgar B, Harman M, Whorwell PJ: Factors preceding relapse of ulcerative colitis. Digestion 00:236-238, 1983
3. 3. Zen L, Anderson FH: Seasonal change in the exacerbations of Crohn's disease. Seand J Gastroenterol 31:79-82, 1996
4. 4. Jewell FM, Davies A, Sandhu B, Duncan A, Grier D. Technetium-99m-HMPAO labelled leukocytes in the detection and monitoring of inflammatory bowel disease in children. Br J Radiol 69:508-514, 1996
5. 5. Giaffer MH: Labelled leukocyte scintigraphy in inflammatory bowel disease: Clinical applications. Gut 38:1-5, 1996
6. 6. Kolkman JJ, Falke THM, Roos JC, et al: Computed tomography and granulocyte scintigraphy in active inflammatory bowel disease. Dig Dis Sci 41(4):641-650, 1996
7. 7. Goldberg PA, Herbst F, Beckett CG, et al: Leukocyte typing, cytokine expression, and epithelial turnover in the ileal pouch in patients with ulcerative colitis and familial adenomatous polyposis. Gut 38:549-553, 1996
8. 8. Leprince E, Andre C, Descos L: Réactions d'hypersensibilité de type I et étiopathogénic de la rectocolite hémorragique. Presse Med 24:1902-1906, 1995
9. 9. Buell MG, Berin MC: Neutrophil-independence of the initiation of colonic injury. Comparison of results from three models of experimental eolitis in the rat. Dig Dis Sci 39( 12):2575-2588, 1994
10. 10. Chin KW, Barret KE: Mast cells are not essential to inflammation in murine model of colitis. Dig Dis Sci 39(3):513-525, 1994
11. 11. Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL: A critical role for Transforming growth factor-β but not interleukin-4 in the suppression of T helper type I-mediated colitis by CD45RB (low) CD4(+) T cells. J Exp Med 183(6):2669-2674, 1996
12. 12. Neurath MF, Fuss I, Kelsall BL, Presky PH, Waegell W, Strober W: Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med 183(6):2605-2616, 1996
13. 13. Nielsen OH, Rask-Madsen J: Mediators of inflammation in chronic inflammatory bowel disease. Scand J Gastroenterol 31(suppl 216):149-159, 1996
14. 14. Grimm MC, Elsbury SKO, Pavli P, Doe WF: Interleukin 8 cells of origin in inflammatory bowel disease. Gut 38:90-98, 1996
15. 15. Arndt H, Bolanowski MA, Granger DN: Role of interleukin-8 on leukocyte-endothelial cell adhesion in intestinal inflammation. Gut 38:911-915, 1996
16. 16. Booth C, Potten CS: Effects of IL-11 on the growth of intestinal epithelial cells in vitro. Cell Prolif 28:581-594, 1995
17. 17. Koutroubakis I, Crusius JBA, Peña AS: Immunogenetics of cytokines. Relevance for future research on inflammatory bowel disease. Scand J Gastroenterol 30:1139-1146, 1995
18. 18. Nielsen OH, Koppen T, Rüdiger N, Horn T, Eriksen J, Kirman I: Involvement of Interleukina-4 and -10 in inflammatory bowel disease. Dig Dis Sci 41(9):1786-1793, 1996
19. 19. Grisham MB, Volkmer C, Tso P, Yamada T: Metabolism of tinitrobencene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology 101:540-547, 1991
20. 20. Grisham MB: Role of reactive oxygen metabolites in inflammatory bowel disease. Curr Opin Gastroenterol 9:971-980, 1993
21. 21. Riehl TE, Stenson WF: Platelet-activating factor acetylhydrolases in Caco 2 cells and epithelium of normal and ulcerative colitis patients. Gastroenterology 109(6):1826-1834, 1995
22. 22. Hugot JP, Laurent-Puig P, Thomas G: Genetic des maladies inflammatories du tube digestif. Gastroenterol Clin Biol 19:890-898, 1995
23. 23. Satsangi J, Grootseholten C, Holt H, Jewell DP: Clinical patterns of familial inflammatory bowel disease. Gut 38:738-741, 1996
24. 24. McDonald TT: Breakdown of tolerance to intestinal bacterial flora in inflammatory bowel disease (IBD). Clin Exp Immunol 102:445-447, 1995
25. 25. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer Zum KH: Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 102:448-455, 1995
26. 26. Elson CO, Balfour R, Sartor G, Tennyson S, Robert H, Ridded L: Experimental models of inflammatory bowel disease. Gastroenterology 109:1344-1367, 1995
27. 27. Morris GP, Beck PL, Heridge MS, Depew WT, Szewczuk, Wallace JL: Hapten-induced models of chronic inflammation and ulceration in the rat colon. Gastroenterology 00:795-803, 1989
28. 28. Stenson WF: Animal models of colitis. Curr Opin Gastroenterol 11:310-315, 1995
29. 29. Council of Europe: European convention for the protection of vertebrate animals used for experimental and other scientific purposes. Addendum III. Strasbourg, 1982
30. 30. Grisham MB, Benon JN, Nen Gragner D: Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol 186:729-741, 1990
31. 31. Dixon WJ, Brown MB, Engelman L. Jennrich RI: BMDP statistical software manual. Berkeley. University of California Press, 1990
32. 32. Krawisz JE. Sharon P. Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 87:1344-1350, 1984
33. 33. Wallace JL, MacNaughton WK, Morris GP, Beck PL: Inhibition of leukotriene synthesis markedly accelerated healing in a rat model of inflammatory bowel disease. Gastroenterology 96:29-36, 1989
34. 34. Higa A, McKnight GW, Wallace JL: Attenuation of epithelial injury in acute experimental colitis by immunomodulators. Eur J Pharmacol 39:171-176, 1993
35. 2 subtype are involved in the immunological inflammatory response of TNBS-induccd enteritis in rats. Agents Actions 38 (Spec No):118-119, 1993
36. 36. Esteve M, Mallolas J, Klaassen J, Lacruz-Abad A, Gónzlaez-Huix F, Cabré E, Fernández-Bañares F, Bertán X, Condom E, Martin-Ragué J, Gassull MA: Anti-neutrophil cytoplasmic antibodies in sera from colectomised ulcerative colitis patients and its relation to the presence of pouchitis. Gut 38:894-898, 1996
37. 37. Yang P, Öresland T, Järnerot G, Hultén L. Danielsson D: Perinuclear anti-neutrophil cytoplasmic antibody in pouchitis after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Scand J Gastroenterol 31:594-598, 1996
38. 38. Eggena M, Targan SR, Twanczyk L, Vidrich A, Gordon LK, Braun J: Phage display cloning and characterization of an immunogenctic marker (perinuclear anti-neutrophil cytoplasmic antibodies) in ulcerative colitis. J Immunol 56:4005-4011, 1996